Nirmatrelvir/Ritonavir Reduces Infection Duration in Hospitalized Hematological Malignancies Patients with Mild-to-Moderate COVID-19: A Retrospective Study
Yu et al., Blood, doi:10.1182/blood-2024-207488
https://c19early.org/yu12.html